393 related articles for article (PubMed ID: 22894890)
21. Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline.
Bandelow B; Bauer M; Vieta E; El-Khalili N; Gustafsson U; Earley WR; Eriksson H
World J Biol Psychiatry; 2014 Feb; 15(2):155-66. PubMed ID: 24506289
[TBL] [Abstract][Full Text] [Related]
22. Generalized anxiety disorder (GAD): efficacy of standardized Matricaria recutita (German chamomile) extract in the treatment of generalized anxiety disorder.
Ross SM
Holist Nurs Pract; 2013; 27(6):366-8. PubMed ID: 24121702
[No Abstract] [Full Text] [Related]
23. An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD).
Cutler NR; Sramek JJ; Macpherson AE; Doss MG; Benes CO; Howard SF
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):685-94. PubMed ID: 7938559
[TBL] [Abstract][Full Text] [Related]
24. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
25. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
[TBL] [Abstract][Full Text] [Related]
26. A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.
Richards EM; Mathews DC; Luckenbaugh DA; Ionescu DF; Machado-Vieira R; Niciu MJ; Duncan WC; Nolan NM; Franco-Chaves JA; Hudzik T; Maciag C; Li S; Cross A; Smith MA; Zarate CA
Psychopharmacology (Berl); 2016 Mar; 233(6):1119-30. PubMed ID: 26728893
[TBL] [Abstract][Full Text] [Related]
27. Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine.
Kasper S; Gastpar M; Müller WE; Volz HP; Möller HJ; Schläfke S; Dienel A
Int J Neuropsychopharmacol; 2014 Jun; 17(6):859-69. PubMed ID: 24456909
[TBL] [Abstract][Full Text] [Related]
28. Specific expectancies are associated with symptomatic outcomes and side effect burden in a trial of chamomile extract for generalized anxiety disorder.
Keefe JR; Amsterdam J; Li QS; Soeller I; DeRubeis R; Mao JJ
J Psychiatr Res; 2017 Jan; 84():90-97. PubMed ID: 27716513
[TBL] [Abstract][Full Text] [Related]
29. A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder.
Mahableshwarkar AR; Jacobsen PL; Serenko M; Chen Y
Hum Psychopharmacol; 2014 Jan; 29(1):64-72. PubMed ID: 24424707
[TBL] [Abstract][Full Text] [Related]
30. Effect of comorbid anxiety on treatment response in bipolar depression.
Tohen M; Calabrese J; Vieta E; Bowden C; Gonzalez-Pinto A; Lin D; Xu W; Corya S
J Affect Disord; 2007 Dec; 104(1-3):137-46. PubMed ID: 17512607
[TBL] [Abstract][Full Text] [Related]
31. Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder.
De Candia MP; Di Sciascio G; Durbano F; Mencacci C; Rubiera M; Aguglia E; Garavini A; Bersani G; Di Sotto A; Placidi G; Cesana BM
Clin Ther; 2009 Dec; 31(12):2851-9. PubMed ID: 20110024
[TBL] [Abstract][Full Text] [Related]
32. Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?
Trivedi MH; Rush AJ; Carmody TJ; Donahue RM; Bolden-Watson C; Houser TL; Metz A
J Clin Psychiatry; 2001 Oct; 62(10):776-81. PubMed ID: 11816866
[TBL] [Abstract][Full Text] [Related]
33. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
[TBL] [Abstract][Full Text] [Related]
34. The comparative clinical study of efficacy of Gamisoyo-San (Jiaweixiaoyaosan) on generalized anxiety disorder according to differently manufactured preparations: multicenter, randomized, double blind, placebo controlled trial.
Park DM; Kim SH; Park YC; Kang WC; Lee SR; Jung IC
J Ethnopharmacol; 2014 Dec; 158 Pt A():11-7. PubMed ID: 25456420
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
Lecrubier Y; Clerc G; Didi R; Kieser M
Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
[TBL] [Abstract][Full Text] [Related]
36. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
37. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
Davidson JR; DuPont RL; Hedges D; Haskins JT
J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
[TBL] [Abstract][Full Text] [Related]
38. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
Silverstone PH; Ravindran A
J Clin Psychiatry; 1999 Jan; 60(1):22-8. PubMed ID: 10074873
[TBL] [Abstract][Full Text] [Related]
39. An exploratory study of salivary cortisol changes during chamomile extract therapy of moderate to severe generalized anxiety disorder.
Keefe JR; Guo W; Li QS; Amsterdam JD; Mao JJ
J Psychiatr Res; 2018 Jan; 96():189-195. PubMed ID: 29080520
[TBL] [Abstract][Full Text] [Related]
40. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
